Kappelman MD, Moore KR, Allen JK, Cook SF (2013) Recent trends in the prevalence of Crohn’s disease and ulcerative colitis in a commercially insured US population. Dig Dis Sci 58:519–25.
Richard N, Savoye G, Leboutte M, Amamou A, Ghosh S, Marion-Letellier R (2023) Crohn’s disease: Why the ileum? World J Gastroenterol 29:3222–40.
Article CAS PubMed PubMed Central Google Scholar
Tabari A, Kilcoyne A, Jeck WR, Mino-Kenudson M, Gee MS (2019) Texture Analysis of Magnetic Resonance Enterography Contrast Enhancement Can Detect Fibrosis in Crohn Disease Strictures. J Pediatr Gastroenterol Nutr 69:533–8.
Bettenworth D, Bokemeyer A, Baker M, Mao R, Parker CE, Nguyen T, Ma C, Panés J, Rimola J, Fletcher JG, Jairath V, Feagan BG, Rieder F (2019) Assessment of Crohn’s disease-associated small bowel strictures and fibrosis on cross-sectional imaging: a systematic review. Gut 68:1115–26.
Article CAS PubMed Google Scholar
Alyami AS (2023) The Role of Radiomics in Fibrosis Crohn’s Disease: A Review. Diagnostics (Basel) 13.
Meng J, Luo Z, Chen Z, Zhou J, Chen Z, Lu B, Zhang M, Wang Y, Yuan C, Shen X, Huang Q, Zhang Z, Ye Z, Cao Q, Zhou Z, Xu Y, Mao R, Chen M, Sun C, Li Z, Feng ST, Meng X, Huang B, Li X (2022) Intestinal fibrosis classification in patients with Crohn’s disease using CT enterography-based deep learning: comparisons with radiomics and radiologists. Eur Radiol 32:8692–705.
Chen W, Lu C, Hirota C, Iacucci M, Ghosh S, Gui X (2017) Smooth Muscle Hyperplasia/Hypertrophy is the Most Prominent Histological Change in Crohn’s Fibrostenosing Bowel Strictures: A Semiquantitative Analysis by Using a Novel Histological Grading Scheme. J Crohns Colitis 11:92–104.
Yu L, Hu S, Huang FC, Wu YC, Zheng XY (2022) Evaluation of dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging for predicting muscular hyperplasia/hypertrophy in Crohn’s disease. Abdom Radiol (NY) 47:1714–24.
Sleiman J, Chirra P, Gandhi NS, Baker ME, Lu C, Gordon IO, Viswanath SE, Rieder F (2022) Crohn’s disease related strictures in cross-sectional imaging: More than meets the eye? United European Gastroenterol J 10:1167–78.
Article PubMed PubMed Central Google Scholar
Ganeshan B, Miles KA (2013) Quantifying tumour heterogeneity with CT. Cancer Imaging 13:140–9.
Article PubMed PubMed Central Google Scholar
Miles KA, Ganeshan B, Hayball MP (2013) CT texture analysis using the filtration-histogram method: what do the measurements mean? Cancer Imaging 13:400–6.
Article PubMed PubMed Central Google Scholar
Li X, Liang D, Meng J, Zhou J, Chen Z, Huang S, Lu B, Qiu Y, Baker ME, Ye Z, Cao Q, Wang M, Yuan C, Chen Z, Feng S, Zhang Y, Iacucci M, Ghosh S, Rieder F, Sun C, Chen M, Li Z, Mao R, Huang B, Feng ST (2021) Development and Validation of a Novel Computed-Tomography Enterography Radiomic Approach for Characterization of Intestinal Fibrosis in Crohn’s Disease. Gastroenterology 160:2303-16.e11.
Makanyanga J, Ganeshan B, Rodriguez-Justo M, Bhatnagar G, Groves A, Halligan S, Miles K, Taylor SA (2017) MRI texture analysis (MRTA) of T2-weighted images in Crohn’s disease may provide information on histological and MRI disease activity in patients undergoing ileal resection. Eur Radiol 27:589–97.
Stidham RW, Enchakalody B, Waljee AK, Higgins PDR, Wang SC, Su GL, Wasnik AP, Al-Hawary M (2020) Assessing Small Bowel Stricturing and Morphology in Crohn’s Disease Using Semi-automated Image Analysis. Inflamm Bowel Dis 26:734–42.
Naziroglu RE, Puylaert CAJ, Tielbeek JAW, Makanyanga J, Menys A, Ponsioen CY, Hatzakis H, Taylor SA, Stoker J, van Vliet LJ, Vos FM (2017) Semi-automatic bowel wall thickness measurements on MR enterography in patients with Crohn’s disease. Br J Radiol 90:20160654.
Article PubMed PubMed Central Google Scholar
van Griethuysen JJM, Fedorov A, Parmar C, Hosny A, Aucoin N, Narayan V, Beets-Tan RGH, Fillion-Robin JC, Pieper S, Aerts H (2017) Computational Radiomics System to Decode the Radiographic Phenotype. Cancer Res 77:e104-e7.
Joost van G (2016) Radiomic Features. Pyradiomics community. https://pyradiomics.readthedocs.io/en/latest/features.html#radiomic-features. Accessed 6 June 2016.
Parmar C, Rios Velazquez E, Leijenaar R, Jermoumi M, Carvalho S, Mak RH, Mitra S, Shankar BU, Kikinis R, Haibe-Kains B, Lambin P, Aerts HJ (2014) Robust Radiomics feature quantification using semiautomatic volumetric segmentation. PLoS One 9:e102107.
Article PubMed PubMed Central Google Scholar
Wang W, Cao K, Jin S, Zhu X, Ding J, Peng W (2020) Differentiation of renal cell carcinoma subtypes through MRI-based radiomics analysis. Eur Radiol 30:5738–47.
Wang J, Lin S, Brown JM, van Wagoner D, Fiocchi C, Rieder F (2021) Novel mechanisms and clinical trial endpoints in intestinal fibrosis. Immunol Rev 302:211–27.
Article CAS PubMed PubMed Central Google Scholar
Solitano V, Dal Buono A, Gabbiadini R, Wozny M, Repici A, Spinelli A, Vetrano S, Armuzzi A (2023) Fibro-Stenosing Crohn’s Disease: What Is New and What Is Next? J Clin Med 12.
Koukoulis G, Ke Y, Henley JD, Cummings OW (2001) Obliterative muscularization of the small bowel submucosa in Crohn disease: a possible mechanism of small bowel obstruction. Arch Pathol Lab Med 125:1331–4.
Article CAS PubMed Google Scholar
Shelley-Fraser G, Borley NR, Warren BF, Shepherd NA (2012) The connective tissue changes of Crohn’s disease. Histopathology 60:1034–44.
Wagner M, Ko HM, Chatterji M, Besa C, Torres J, Zhang X, Panchal H, Hectors S, Cho J, Colombel JF, Harpaz N, Taouli B (2018) Magnetic Resonance Imaging Predicts Histopathological Composition of Ileal Crohn’s Disease. J Crohns Colitis 12:718–29.
Article PubMed PubMed Central Google Scholar
Fatehi F, Salort-Campana E, Le Troter A, Lareau-Trudel E, Bydder M, Fouré A, Guye M, Bendahan D, Attarian S (2017) Long-term follow-up of MRI changes in thigh muscles of patients with Facioscapulohumeral dystrophy: A quantitative study. PLoS One 12:e0183825.
Article PubMed PubMed Central Google Scholar
Shimizu-Motohashi Y, Chiba E, Mizuno K, Yajima H, Ishiyama A, Takeshita E, Sato N, Oba M, Sasaki M, Ito S, Komaki H (2023) Muscle impairment in MRI affect variability in treatment response to nusinersen in patients with spinal muscular atrophy type 2 and 3: A retrospective cohort study. Brain Dev 45:161–70.
Comments (0)